Short answer
Azenta, Inc. (AZTA) filed its Q4 2025 10-Q quarterly report on Feb 5, 2026 for the quarter ended Dec 31, 2025. Quarterly revenue was $149M (up 0.8% year over year) with net income of −$15M.
Q4 2025 key financials · XBRL
- Revenue
- $149M
- +0.8% YoY
- Net income
- −$15M
- −15.7% YoY
- Operating margin
- -4.9%
- Gross margin
- 42.9%
- EPS (diluted)
- −$0.34
- −17.2% YoY
Source: XBRL data from the Azenta, Inc. (AZTA) Q4 2025 10-Q on SEC EDGAR. USD.
Azenta, Inc. Q4 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $148.6M, up 0.8% YoY; Sample Management Solutions $81.4M up 0.4%, Multiomics $67.2M up 1.4%
- Operating margin Sample Management 4.6% vs 5.0% YoY, Multiomics -7.5% vs -4.8%, total company -0.9% vs 0.6%
- Best segment Sample Management Solutions adjusted margin 6.1% vs 5.9%; worst Multiomics adjusted margin -6.5% vs -3.5%
- Gross margin total 42.9% vs 46.7% YoY; Sample Management 43.9% vs 48.2%, Multiomics 41.5% vs 44.8%
- Selling, general & admin expenses $60.6M, down $9.4M YoY mainly from lower compensation and one-time costs
Risk Factors
- No new or materially updated risk factors disclosed this quarter compared to 2025 10-K
- Continued risk of intellectual property disputes impacting proprietary technology and trademarks
- Dependence on accuracy of third-party industry data and assumptions introduces uncertainty to market forecasts
- Market position and opportunity assessments subject to high degree of risk and changing industry conditions
- No specific financial risks such as liquidity or debt maturity changes detailed in this filing
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Azenta, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.